Cannabis Stocks

Cannabis Reports Highlight $339M And $297.6M Revenue Insights In Curaleaf And Trulieve's Q1 2024 Financials
Q1 2024: MariMed's Revenue Rises To $37.9M, Amid Declining Gross Margin
Post Cannabis Rescheduling: What's Next For Marijuana Giants? Potential $1.1B Cash Flow Boost From IRS 280E Removal
Q1 2024: MariMed's Revenue Rises To $37.9M, Amid Declining Gross Margin
Post Cannabis Rescheduling: What's Next For Marijuana Giants? Potential $1.1B Cash Flow Boost From IRS 280E Removal
EXCLUSIVE: 'Cannabis Is Just Getting Started,' Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles

Cannabis Stocks Recent News

How Big Caps Rewrite Valuation Rules In Cannabis: Cash Puzzle For Companies Above And Below $500M
How do we look at cannabis companies' cash flow? What is their total value and what methods are used to assess their worth?
Investors Shuffle Stock Positions In Aurora Cannabis: Beyond Earnings, Liquidity Looks Appealing
Aurora Cannabis Inc. captured investor attention with a dramatic 38% increase in options trading and a significant 18.2% surge in stock price in a single trading day. These movements underscore a robust financial period for the company, which reported quarterly revenues of $53.34 million, surpassing expectations by nearly 16%.
Who's Winning In Weed? Analyst Looks At Cannabis Market's Big Players, Where Are The Best Bets?
In the first quarter of 2024, the cannabis sector faces a mixed economic landscape with a notable sequential decline in sales across several states.
Beyond Amazon And Coca-Cola: Why Cannabis Is Catching Up To Blue Chip Stocks In Profitability
A recent report by Viridian Capital Advisors explores the valuation and growth prospects of cannabis stocks against those of well-established sectors like alco
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis industry.
Gold Flora's Strategic Cannabis Blueprint: 30% In-House Sales Boost, Profits, EBITDA Rise
In recent evaluations by Zuanic & Associates and Water Tower Research LLC, Gold Flora Corporation (OTC: GRAM), a key player in the competitive California cannabis market, reported its financial outcomes for the fourth quarter of 2023.
Mortgage And Property Finance Giant's $354M Portfolio: Growth Amid Cannabis Sector Volatility
In a recent equity research report by Zuanic & Associates, Chicago Atlantic Real Estate Finance (NASDAQ: REFI) showcases resilience and growth within the volatile cannabis sector.
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector.
This Dividend-Paying Cannabis Stock Had Higher 1-Year Return Than Tesla, Citigroup, Apple And Zillow
If you added cannabis-focused real estate investment trust – Innovative Industrial Properties (NYSE:IIPR) about a year ago, you’d be enjoying solid returns.
NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?
The Canadian cannabis sector is witnessing a notable upswing, driven by recent developments including Tilray's (NASDAQ: TLRY) earnings report, Organigram's investor day (NASDAQ: OGI) and pivotal movements by Canopy Growth (NASDAQ:
Florida's $6B Cannabis Market Anticipates 400% Growth Following Court Decision Allowing Nov. Legalization Ballot
Following the pivotal decision by the Florida Supreme Court, senior analyst Pablo Zuanic of Zuanic & Associates released a comprehensive report outlining the potent
Heritage Cannabis' Stock Plunges On Announcing Creditor Protection, Looks To Pursue Restructuring And Sales Process
Heritage Cannabis Holdings Corp. announced on Tuesday that alongside its subsidiaries it sought and obtained an order for creditor protection from the Ontario Superior Court of Justice under the Companies Creditors Arrangement Act. "The difficult but necessary decision to commence CCAA proceedings was made after careful consideration of the Company's financial position while evaluating all available alternatives and engaging in significant consultation with legal and financial advisors," the company said in a press release. The Toronto-based cannabis producer also said that BJK Holdings Ltd., its senior secured lender, made a demand to the company for payment in full of certain indebtedness owing by the Heritage Group to the lender totaling $8,421,088.87. Heritage has entered into binding agreements to sell its real estate properties in Ontario and British Columbia to BJK Developments Ltd. for a net purchase price of $9,714,475 and lease the Ontario and BC Property back from the purchaser in October. The company said at the time the purchase would be used to set off the amount owing by the company to its lender, BJK Holdings Ltd., a related entity of the purchaser, reducing the company's remaining term debt by roughly 64% to $5,256,379. The remaining term financing, as amended within a third amending agreement, has been extended through to Jan. 31, 2025. Additionally, the company said it retains its revolving line of credit of up to $5 million with BJK, which has also been extended until the same date.
Green Gold Rush: Here's What's Driving Cannabis Stocks Higher
Various themes and sectors garnered buzz and attention as the first quarter drew to a close. However, one industry that has been in a lull for a significant period reignited the imagination and hope of longstanding investors after it finished the first quarter in style. 
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.
California's Weed Sales Decline: Market Ripe For Consolidation, Biggest Companies Likely To Benefit
The California cannabis sector is facing a sales decline, according to a recent market update from Pablo Zuanic, senior equity research analyst at Zuanic & Associates.
Cannabis Stocks Set To Dominate Germany's New Market: A Surge In Demand Meets Established Expertise
Germany's historic step towards cannabis legalization, effective April 1, 2024, opens a new chapter in the global cannabis industry, presenting substantial opportunities for Canadian leaders Aurora (NASDAQ: ACB), Canopy Growth (NASDAQ: CGC), and Tilra
How Did MariMed Cannabis Company's Revenue Surge By 48%? Find Out At Benzinga Cannabis Capital Conference
MariMed, Inc. has embarked on a remarkable journey, boasting a 48% increase in wholesale revenue in 2023 and projecting over 20% growth for 2024. Under the leadership of CEO Jon Levine, the company has navigated through regulatory uncertainties and competitive market headwinds with strategic expansions and product innovation.
VP Harris, DEA, FDA Eye Cannabis: Key Changes Ahead, Here's What One Expert Predicts
Vice President Harris's urgent call to the DEA to expedite the rescheduling of cannabis marks a crucial turning point in national drug policy, as analyzed in a comprehensive equity research report by Zuanic & Associates.
Inflation Rattles Markets Ahead Of Fed Meeting; AI Stocks, Crypto Pause As Gold, Oil Advance: This Week In The Markets
Inflation reports unveiled in the week preceding the Fed meeting brought an unwelcome news to investors.
Cannabis Stocks Jump On News That DEA May Soon Undertake Marijuana Reform
Doug Kass, world-renowned hedge fund manager, posted on X, formerly Twitter, Friday that the "DEA will approve a rescheduling of cannabis to Schedule III." 
Jushi Beats All Expectations: Cannabis Company Surpasses Analysts' 4Q23 Sales And Profit Forecasts
The multi-state cannabis company Jushi Holdings (OTC: JUSHF), reported a significant increase in unique patient visits in Virginia, indicating robust growth in the fourth quarter of 2023.
NASDAQ-Listed Village Farms Grabs #2 Spot In Canada's Cannabis Market: What's Its Winning Formula?
Cannabis company Village Farms International, Inc. (NASDAQ: VFF) is making noteworthy strides, securing the #2 position in the recreational cannabis market in Canada.
Green Thumb's Edge Over S&P 500 & ETFs: Cannabis Investor Confidence Propels Expansion Into Key States
Green Thumb Industries Inc. (OTC: GTBIF) is ramping up investments across Minnesota, Ohio, Virginia, Florida and Pennsylvania to gear up for recreational marijuana legalization.